95 related articles for article (PubMed ID: 34897998)
1. Targeting UBR5 inhibits postsurgical breast cancer lung metastases by inducing CDC73 and p53 mediated apoptosis.
Yu Z; Dong X; Song M; Xu A; He Q; Li H; Ouyang W; Chouchane L; Ma X
Int J Cancer; 2024 Feb; 154(4):723-737. PubMed ID: 37855385
[TBL] [Abstract][Full Text] [Related]
2. A review: targeting UBR5 domains to mediate emerging roles and mechanisms: chance or necessity?
Wang Y; Niu K; Shi Y; Zhou F; Li X; Li Y; Chen T; Zhang Y
Int J Surg; 2024 May; ():. PubMed ID: 38701508
[TBL] [Abstract][Full Text] [Related]
3. Orphan quality control shapes network dynamics and gene expression.
Mark KG; Kolla S; Aguirre JD; Garshott DM; Schmitt S; Haakonsen DL; Xu C; Kater L; Kempf G; Martínez-González B; Akopian D; See SK; Thomä NH; Rapé M
Cell; 2023 Aug; 186(16):3460-3475.e23. PubMed ID: 37478862
[TBL] [Abstract][Full Text] [Related]
4. Harnessing UBR5 for targeted protein degradation of key transcriptional regulators.
Taherbhoy AM; Daniels DL
Trends Pharmacol Sci; 2023 Nov; 44(11):758-761. PubMed ID: 37770316
[TBL] [Abstract][Full Text] [Related]
5. Expression of concern: MRE11 and UBR5 co-operate to suppress RNF168-mediated fusion of dysfunctional telomeres.
Frontiers Editorial Office
Front Oncol; 2023; 13():1308554. PubMed ID: 38144537
[No Abstract] [Full Text] [Related]
6. Comparative proteomic profiling of uric acid, ammonium acid urate, and calcium-based kidney stones.
Khusid JA; Vasquez A; Sadiq AS; Stockert JA; Gallante B; Yaghoubian A; Shimonov R; Stock A; Atallah W; Kyprianou N; Yang W; Gupta M
Am J Clin Exp Urol; 2023; 11(3):265-274. PubMed ID: 37441444
[TBL] [Abstract][Full Text] [Related]
7. The role of UBR5 in tumor proliferation and oncotherapy.
Hu B; Chen S
Gene; 2024 May; 906():148258. PubMed ID: 38331119
[TBL] [Abstract][Full Text] [Related]
8. BoxCar and shotgun proteomic analyses reveal molecular networks regulated by UBR5 in prostate cancer.
Yan Y; Zhou B; Lee YJ; You S; Freeman MR; Yang W
Proteomics; 2022 Feb; 22(4):e2100172. PubMed ID: 34897998
[TBL] [Abstract][Full Text] [Related]
9. Modulation of myocardin function by the ubiquitin E3 ligase UBR5.
Hu G; Wang X; Saunders DN; Henderson M; Russell AJ; Herring BP; Zhou J
J Biol Chem; 2010 Apr; 285(16):11800-9. PubMed ID: 20167605
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of the proapoptotic protein MOAP-1 by the UBR5 ubiquitin ligase and its role in ovarian cancer resistance to cisplatin.
Matsuura K; Huang NJ; Cocce K; Zhang L; Kornbluth S
Oncogene; 2017 Mar; 36(12):1698-1706. PubMed ID: 27721409
[TBL] [Abstract][Full Text] [Related]
11. Functional Roles of the E3 Ubiquitin Ligase UBR5 in Cancer.
Shearer RF; Iconomou M; Watts CK; Saunders DN
Mol Cancer Res; 2015 Dec; 13(12):1523-32. PubMed ID: 26464214
[TBL] [Abstract][Full Text] [Related]
12. UBR5 is a novel E3 ubiquitin ligase involved in skeletal muscle hypertrophy and recovery from atrophy.
Seaborne RA; Hughes DC; Turner DC; Owens DJ; Baehr LM; Gorski P; Semenova EA; Borisov OV; Larin AK; Popov DV; Generozov EV; Sutherland H; Ahmetov II; Jarvis JC; Bodine SC; Sharples AP
J Physiol; 2019 Jul; 597(14):3727-3749. PubMed ID: 31093990
[TBL] [Abstract][Full Text] [Related]
13. Identification of phosphorylation sites on the E3 ubiquitin ligase UBR5/EDD.
Bethard JR; Zheng H; Roberts L; Eblen ST
J Proteomics; 2011 Dec; 75(2):603-9. PubMed ID: 21924388
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]